Magnetic Insight
Series B in 2022
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
Aligned Carbon
Convertible Note in 2022
Aligned Carbon Inc. is a manufacturer of carbon nanotubes (CNTs) specifically designed for the integrated circuit industry. Established in 2018 and headquartered in Santa Clara, California, the company produces semiconductor-pure, aligned CNTs that are available on industry-standard wafers at a manufacturing scale. These CNTs are uniquely aligned in arrays that cover full semiconductor substrates and can be purified to be either entirely semiconducting or metallic. Aligned Carbon's technology facilitates a transition away from traditional silicon, allowing semiconductor foundries to achieve significant improvements in speed, energy efficiency, and performance in applications such as logic processing, signal processing, and advanced sensing technologies. The company's innovations enable clients to enhance computing applications through the integration of carbon nanotube logic with conventional silicon logic and memory, thereby addressing growing demands in the semiconductor sector.
Magnetic Insight
Series B in 2021
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
Nanochon
Seed Round in 2021
Nanochon is developing an implantable, 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth in joints, with a focus on knee damage. The device combines 3D printing and a novel nanomaterial to enable on-demand, cost-effective solutions intended to restore joint function and improve outcomes for young and active patients.
Aligned Carbon
Seed Round in 2021
Aligned Carbon Inc. is a manufacturer of carbon nanotubes (CNTs) specifically designed for the integrated circuit industry. Established in 2018 and headquartered in Santa Clara, California, the company produces semiconductor-pure, aligned CNTs that are available on industry-standard wafers at a manufacturing scale. These CNTs are uniquely aligned in arrays that cover full semiconductor substrates and can be purified to be either entirely semiconducting or metallic. Aligned Carbon's technology facilitates a transition away from traditional silicon, allowing semiconductor foundries to achieve significant improvements in speed, energy efficiency, and performance in applications such as logic processing, signal processing, and advanced sensing technologies. The company's innovations enable clients to enhance computing applications through the integration of carbon nanotube logic with conventional silicon logic and memory, thereby addressing growing demands in the semiconductor sector.
NS Nanotech
Seed Round in 2021
Founded in 2018, NS Nanotech specializes in developing nano-LED technology for various applications. Their patented nitride semiconductors emit light in the visible RGB spectrum for display technologies and in the invisible UV spectrum for far-UVC disinfection. This enables safer, more efficient, and environmentally friendly solutions compared to traditional germicidal UVC lamps.
Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery.
As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research.
It was founded in 2013 and is based in San Diego, California.
Flux Biosciences
Venture Round in 2020
Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.
NS Nanotech
Pre Seed Round in 2019
Founded in 2018, NS Nanotech specializes in developing nano-LED technology for various applications. Their patented nitride semiconductors emit light in the visible RGB spectrum for display technologies and in the invisible UV spectrum for far-UVC disinfection. This enables safer, more efficient, and environmentally friendly solutions compared to traditional germicidal UVC lamps.
Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery.
As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research.
It was founded in 2013 and is based in San Diego, California.
Magnetic Insight
Series A in 2018
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
Flux Biosciences
Seed Round in 2018
Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.
BotFactory
Convertible Note in 2018
BotFactory develops and manufactures desktop electronic circuit printers. Its flagship product, Squink, enables users to design and create 3D printed electronic prototypes using print conductive ink, dispense solder paste or glue, and pick and place components. BotFactory serves Fortune 500 research labs, aerospace companies, universities, and electronics makers, accelerating their prototyping processes.
Magnetic Insight
Convertible Note in 2017
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
BotFactory
Venture Round in 2016
BotFactory develops and manufactures desktop electronic circuit printers. Its flagship product, Squink, enables users to design and create 3D printed electronic prototypes using print conductive ink, dispense solder paste or glue, and pick and place components. BotFactory serves Fortune 500 research labs, aerospace companies, universities, and electronics makers, accelerating their prototyping processes.
BotFactory
Venture Round in 2016
BotFactory develops and manufactures desktop electronic circuit printers. Its flagship product, Squink, enables users to design and create 3D printed electronic prototypes using print conductive ink, dispense solder paste or glue, and pick and place components. BotFactory serves Fortune 500 research labs, aerospace companies, universities, and electronics makers, accelerating their prototyping processes.
Magnetic Insight
Seed Round in 2016
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery.
As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research.
It was founded in 2013 and is based in San Diego, California.
Nanotech Biomachines
Venture Round in 2015
Nanotech Biomachines specializes in advanced sensor technology aimed at transforming therapeutic discovery and development. The company leverages modern electronic materials and straightforward membrane preparations to achieve high sensitivity and specificity in measuring real-time binding to integral membrane proteins (IMPs). This innovative approach is mass-independent, cell-free, and label-free, allowing for direct electronic output using native IMPs in fluid membranes. By providing clients with this cutting-edge sensor technology, Nanotech Biomachines enhances the efficiency and effectiveness of the drug discovery process, positioning itself at the forefront of 21st-century medicine development.
Nanomed
Venture Round in 2015
Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery.
As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research.
It was founded in 2013 and is based in San Diego, California.
Nanotech Biomachines
Venture Round in 2014
Nanotech Biomachines specializes in advanced sensor technology aimed at transforming therapeutic discovery and development. The company leverages modern electronic materials and straightforward membrane preparations to achieve high sensitivity and specificity in measuring real-time binding to integral membrane proteins (IMPs). This innovative approach is mass-independent, cell-free, and label-free, allowing for direct electronic output using native IMPs in fluid membranes. By providing clients with this cutting-edge sensor technology, Nanotech Biomachines enhances the efficiency and effectiveness of the drug discovery process, positioning itself at the forefront of 21st-century medicine development.
Agoura Technologies
Venture Round in 2007
Agoura Technologies, Inc., a nanotechnology company, develops optical films.